SCHEMBL6167020

SCHEMBL6167020

CN([SiH](C)C)[Si](C)(C)C.COCC#Cc1cc(Cl)c(Nc2ncnc3cc(OCCCN4CCOCC4)c(OC)cc23)c2c1OCO2.[Na]

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SRC P12931 16/20 0.63
KDR P35968 11/20 0.63
CSK P41240 2/20 0.63
TEK Q02763 2/20 0.63
EPHB4 P54760 2/20 0.55
EGFR P00533 4/20 0.53
CIT O14578 1/20 0.52
GAK O14976 1/20 0.52
EPHB6 O15197 1/20 0.52
ABCC4 O15439 1/20 0.52
DAPK3 O43293 1/20 0.52
RIPK2 O43353 1/20 0.52
NR1I2 O75469 1/20 0.52
RPS6KA4 O75676 1/20 0.52
STK17B O94768 1/20 0.52
STK10 O94804 1/20 0.52
PRKD3 O94806 1/20 0.52
ABCB11 O95342 1/20 0.52
MAP4K4 O95819 1/20 0.52
CHEK2 O96017 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6167015 0.99 SRC (0.63) SRCKDRCSKTEKEPHB4
SCHEMBL4023995 0.93 SRC (0.72) SRCKDRCSKTEKEPHB4
SCHEMBL4031671 0.91 SRC (0.69) SRCKDRCSKTEKEPHB4
SCHEMBL6167012 0.90 SRC (0.68) SRCKDRCSKTEKEPHB4
SCHEMBL4032303 0.90 SRC (0.66) SRCKDRCSKTEKEPHB4
SCHEMBL4022854 0.89 SRC (0.68) SRCKDRCSKTEKEPHB4
SCHEMBL4025065 0.88 SRC (0.69) SRCKDRCSKTEKEPHB4
SCHEMBL4021199 0.88 SRC (0.68) SRCKDRCSKTEKEPHB4
SCHEMBL4024497 0.88 SRC (0.70) SRCKDRCSKTEKEPHB4
SCHEMBL4024097 0.87 SRC (0.68) SRCKDRCSKTEKEPHB4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1528925-A1 QUINAZOLINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER Astrazeneca AB (SE) 2005-05-11 EP disclosed
WO-2004004732-A1 QUINAZOLINE DERIVATIVES FOR USE IN THE TREATMENT OF CANCER ASTRAZENECA AB (SE) 2004-01-15 WO disclosed